Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Pathol ; 183(3): 673-80, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23831296

ABSTRACT

Oligodendrocytes exhibit a limited capacity to remyelinate in multiple sclerosis. Factors present in multiple sclerosis lesions are thought to inhibit oligodendrocyte precursor cell migration, limiting their recruitment to axons requiring remyelination; however, few inhibitors have been identified. A candidate inhibitor is netrin-1, a secreted protein that repels migrating oligodendrocyte precursor cells during neural development and is expressed by myelinating oligodendrocytes in the mature rodent central nervous system. Herein, we examined the distribution of netrin-1 in adult human white matter and multiple sclerosis lesions. We detected full-length netrin-1 protein and shorter netrin-1 fragments in samples of normal white matter and of multiple sclerosis lesions from adult human brain. We demonstrate that peptides corresponding to amino terminal domains VI and V of netrin-1 repel migrating oligodendrocyte precursor cells, but lack the chemoattractant activity of full-length netrin-1. Furthermore, recombinant domains VI-V of netrin-1 disrupt the chemoattractant activity of full-length netrin-1, consistent with a competitive mechanism of action. These findings indicate that full-length and fragmented forms of netrin-1, found in multiple sclerosis lesions, have the capacity to inhibit oligodendrocyte precursor migration, identifying netrin-1 as a potential target for therapies that promote remyelination.


Subject(s)
Cell Movement , Multiple Sclerosis/metabolism , Multiple Sclerosis/pathology , Nerve Growth Factors/metabolism , Oligodendroglia/metabolism , Oligodendroglia/pathology , Stem Cells/pathology , Tumor Suppressor Proteins/metabolism , Adult , Aged , Animals , Brain/metabolism , Brain/pathology , Chickens , Child , Female , HEK293 Cells , Humans , Male , Middle Aged , Nerve Growth Factors/chemistry , Netrin-1 , Peptide Fragments/chemistry , Peptide Fragments/metabolism , Protein Structure, Tertiary , Rats , Rats, Sprague-Dawley , Stem Cells/metabolism , Tumor Suppressor Proteins/chemistry
2.
Mol Cell Biol ; 31(2): 238-47, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21059867

ABSTRACT

The Rb/E2F pathway has long been appreciated for its role in regulating cell cycle progression. Emerging evidence indicates that it also influences physiological events beyond regulation of the cell cycle. We have previously described a requirement for Rb/E2F mediating neuronal migration; however, the molecular mechanisms remain unknown, making this an ideal system to identify Rb/E2F-mediated atypical gene regulation in vivo. Here, we report that Rb regulates the expression of neogenin, a gene encoding a receptor involved in cell migration and axon guidance. Rb is capable of repressing E2F-mediated neogenin expression while E2F3 occupies a region containing E2F consensus sites on the neogenin promoter in native chromatin. Absence of Rb results in aberrant neuronal migration and adhesion in response to netrin-1, a known ligand for neogenin. Increased expression of neogenin through ex vivo electroporation results in impaired neuronal migration similar to that detected in forebrain-specific Rb deficiency. These findings show direct regulation of neogenin by the Rb/E2F pathway and demonstrate that regulation of neogenin expression is required for neural precursor migration. These studies identify a novel mechanism through which Rb regulates transcription of a gene beyond the classical E2F targets to regulate events distinct from cell cycle progression.


Subject(s)
Cell Movement/physiology , E2F3 Transcription Factor/metabolism , Gene Expression Regulation, Developmental , Membrane Proteins/metabolism , Neurons/physiology , Retinoblastoma Protein/metabolism , Animals , Cell Adhesion/physiology , E2F3 Transcription Factor/genetics , HEK293 Cells , Humans , Membrane Proteins/genetics , Mice , Mice, Knockout , Nerve Growth Factors/genetics , Nerve Growth Factors/metabolism , Netrin-1 , Neurons/cytology , Promoter Regions, Genetic , Prosencephalon/anatomy & histology , Prosencephalon/embryology , Prosencephalon/metabolism , Retinoblastoma Protein/genetics , Transcription, Genetic , Tumor Suppressor Proteins/genetics , Tumor Suppressor Proteins/metabolism
3.
Mol Cancer Res ; 3(4): 183-94, 2005 Apr.
Article in English | MEDLINE | ID: mdl-15831672

ABSTRACT

Crk adaptor proteins play an important role during cellular signaling by mediating the formation of protein complexes. Increased levels of Crk proteins are observed in several human cancers and overexpression of Crk in epithelial cell cultures promotes enhanced cell dispersal and invasion, implicating Crk as a regulator of invasive responses. To determine the requirement of Crk for invasive signals, we targeted the CRKI/II gene by RNA interference. Consistent knockdown of CrkI/II was observed with two small interfering RNA targeting sequences in all human cancer cell lines tested. CrkI/II knockdown resulted in a significant decrease in migration and invasion of multiple malignant breast and other human cancer cell lines (MDA-231, MDA-435s, H1299, KB, and HeLa). Moreover, CrkI/II knockdown decreased cell spreading on extracellular matrix and led to a decrease in actin stress fibers and the formation of mature focal adhesions. Using immunohistochemistry, we show elevated CrkI/II protein levels in patients with breast adenocarcinoma. Together, these studies identify Crk adaptor proteins as critical integrators of upstream signals for cell invasion and migration in human cancer cell lines and support a role for Crk in metastatic spread.


Subject(s)
Adenocarcinoma/secondary , Breast Neoplasms/pathology , Proto-Oncogene Proteins/metabolism , Signal Transduction/physiology , Adenocarcinoma/metabolism , Breast Neoplasms/metabolism , Cell Adhesion/physiology , Cell Movement/physiology , HeLa Cells , Humans , Neoplasm Invasiveness , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins c-crk , RNA, Small Interfering , Stress Fibers/metabolism
4.
J Infect Dis ; 186(8): 1122-30, 2002 Oct 15.
Article in English | MEDLINE | ID: mdl-12355363

ABSTRACT

Piperidine is a 1-ring heterocyclic compound formed from the polyamine cadaverine in the human intestine. Because heterocyclic compounds are routinely used in the promotion of antimicrobial treatment strategies, it was considered whether piperidine could be used against infection with enteric pathogens. This study demonstrates that piperidine treatment prevented the invasion of Salmonella typhimurium into model intestinal epithelium by nearly 95%. In vivo studies also revealed that it increased mouse survival and reduced S. typhimurium translocation into and colonization of various organs and tissues. Initial evaluations demonstrated that piperidine reduced the S. typhimurium-induced polymorphonuclear leukocyte transepithelial migration response in vitro by inhibiting activation of protein kinase C. Piperidine did not affect the ability of S. typhimurium to elicit interleukin-8 secretion by epithelial cells or to activate extracellular-regulated kinase signal transduction pathways. These results show that piperidine does not exhibit paninhibitory activity and suggest that piperidine may be useful in down-regulating active inflammation at mucosal surfaces.


Subject(s)
Cadaverine/metabolism , Piperidines/metabolism , Piperidines/pharmacology , Salmonella typhimurium/drug effects , Salmonella typhimurium/pathogenicity , Animals , Cell Migration Inhibition , Cell Polarity , Cells, Cultured , Chemotaxis, Leukocyte/drug effects , Epithelial Cells/drug effects , Epithelial Cells/metabolism , Epithelial Cells/microbiology , Humans , Interleukin-8/metabolism , Male , Mice , Mice, Inbred BALB C , Neutrophils , Phosphorylation , Protein Kinase C/metabolism , Salmonella typhimurium/growth & development , Salmonella typhimurium/physiology
5.
Infect Immun ; 70(3): 1150-8, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11854195

ABSTRACT

An early step governing Shigella flexneri pathogenesis is the invasion of the colonic epithelium from the basolateral surface followed by disruption of the colonic epithelial barrier. Despite recent insight into S. flexneri-host interactions, much remains to be determined regarding the nature of the initial contact between S. flexneri and the host epithelial basolateral membrane domain. Since the lipopolysaccharide (LPS) is located at the outermost part of the bacterial membrane, we considered that this component might be used by S. flexneri to attach to the basolateral surface of the intestinal epithelium and promote a proinflammatory response. Therefore, polarized human T84 intestinal epithelial cells were infected from the basolateral surface with either wild-type S. flexneri or one of its isogenic LPS-defective strains with mutations in either rfc, rfaL, or galU. We found that both adherence to and internalization into the basolateral surface of a polarized intestinal epithelium with S. flexneri were highly dependent on the length of the LPS (i.e., rfc > rfaL > galU). Furthermore, the addition of the anti-inflammatory LPS (RsDPLA) considerably decreased the invasion profile of wild-type S. flexneri by nearly 50%. Since LPS is associated with host inflammation, we further examined whether this molecule was involved in Shigella-induced inflammatory events. We found that S. flexneri LPS plays an important role in mediating epithelial-derived signaling, which leads to directed migration of polymorphonuclear leukocytes across model intestinal epithelium. This signaling most likely involves the activation of the mitogen-activated protein kinase extracellular regulated kinase. Thus, our findings have important implications on the understanding of the mechanisms by which S. flexneri can elicit mucosal inflammation.


Subject(s)
Cell Polarity , Intestinal Mucosa/microbiology , Lipopolysaccharides/pharmacology , Mitogen-Activated Protein Kinases/metabolism , Shigella flexneri/pathogenicity , Cells, Cultured , Enzyme Inhibitors , Flavonoids/pharmacology , Intestinal Mucosa/cytology , Intestinal Mucosa/enzymology , Neutrophils/immunology , Signal Transduction
SELECTION OF CITATIONS
SEARCH DETAIL
...